Gyre Therapeutics (GYRE) Accumulated Depreciation & Amortization: 2011-2025
Historic Accumulated Depreciation & Amortization for Gyre Therapeutics (GYRE) over the last 2 years, with Sep 2025 value amounting to $6.9 million.
- Gyre Therapeutics' Accumulated Depreciation & Amortization rose 30.26% to $6.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.0 million, marking a year-over-year increase of 31.32%. This contributed to the annual value of $5.6 million for FY2024, which is 31.28% up from last year.
- Per Gyre Therapeutics' latest filing, its Accumulated Depreciation & Amortization stood at $6.9 million for Q3 2025, which was up 7.92% from $6.4 million recorded in Q2 2025.
- In the past 5 years, Gyre Therapeutics' Accumulated Depreciation & Amortization ranged from a high of $6.9 million in Q3 2025 and a low of $4.0 million during Q4 2022.
- For the 3-year period, Gyre Therapeutics' Accumulated Depreciation & Amortization averaged around $5.5 million, with its median value being $5.5 million (2024).
- Data for Gyre Therapeutics' Accumulated Depreciation & Amortization shows a peak YoY skyrocketed of 33.74% (in 2025) over the last 5 years.
- Quarterly analysis of 4 years shows Gyre Therapeutics' Accumulated Depreciation & Amortization stood at $4.0 million in 2022, then rose by 6.68% to $4.3 million in 2023, then soared by 31.28% to $5.6 million in 2024, then surged by 30.26% to $6.9 million in 2025.
- Its Accumulated Depreciation & Amortization stands at $6.9 million for Q3 2025, versus $6.4 million for Q2 2025 and $6.1 million for Q1 2025.